Rituximab for treatment-resistant schizophrenia and/or obsessive-compulsive disorder (OCD): functional connectivity and cytokines associated with symptomatic improvementsEUROPEAN PSYCHIATRYIF6.72023-07-190OAAI
Alterations in inflammasome-related immunometabolites in individuals with severe psychiatric disordersBMC PSYCHIATRYIF3.62023-04-192OAAI
Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patientsJOURNAL OF PSYCHIATRIC RESEARCHIF3.22023-02-0111OAAI
Rituximab for treatment resistant schizophrenia spectrum disorder and/or obsessive compulsive disorderBRAIN BEHAVIOR AND IMMUNITYIF7.62022-11-010PRE
Dysregulated inflammasome associated polar metabolites in a transdiagnostic cohort of severely ill psychiatric patientsBRAIN BEHAVIOR AND IMMUNITYIF7.62022-11-010PRE
An Internet Based Intervention for Adults With Autism Spectrum Disorder-A Qualitative Study of Participants ExperiencesFRONTIERS IN PSYCHIATRYIF3.22021-12-2210OAAI
Joint Hypermobility in Paediatric Acute-Onset Neuropsychiatric Syndrome-A Preliminary Case-Control StudyFRONTIERS IN PSYCHIATRYIF3.22021-12-033OAAI
Potential Transdiagnostic Lipid Mediators of Inflammatory Activity in Individuals With Serious Mental IllnessFRONTIERS IN PSYCHIATRYIF3.22021-11-265OAAI
Feeling safe or unsafe in psychiatric inpatient care, a hospital-based qualitative interview study with inpatients in Swedeninternational journal of mental health nursingIF3.82019-04-0850OAAI
Psychosocial work environment within psychiatric inpatient care in Sweden: Violence, stress, and value incongruence among nursing staffINTERNATIONAL JOURNAL OF MENTAL HEALTH NURSINGIF3.32017-11-2833OAAI